ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE
<p><strong>Aim.</strong> To analyze the impact of the SLCO1B1*5 (c.521T> C) and LIPC (C514T) genes polymorphisms on the efficacy of atorvastatin therapy and the incidence of the combined endpoint in patients after myocardial infarction (MI).</p><p><strong>Mater...
Saved in:
Main Authors: | M. V. Solodun (Author), S. S. Yakushin (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE
by: M. V. Solodun, et al.
Published: (2015) -
PREDICTORS OF LONG-TERM PROGNOSIS OF MYOCARDIAL INFARCTION: FOCUS ON THE PHARMACOKINETICS
by: M. V. Solodun, et al.
Published: (2016) -
Dose-dependent effects of atorvastatin on myocardial infarction
by: Barbarash O, et al.
Published: (2015) -
Use of lipid-lowering therapy preceding first hospitalization for acute myocardial infarction or stroke
by: Alexander T. Sandhu, et al.
Published: (2022) -
Protective effects of atorvastatin and quercetin on isoprenaline-induced myocardial infarction in rats
by: Mai A. Zaafan, et al.
Published: (2013)